Specific alterations of carbohydrate metabolism are associated with hepatocarcinogenesis in mitochondrially impaired mice

Human Molecular Genetics

Volumn 21, Issue 3, 2012, Pages 656-663

  Thierbach, René ^a   Florian, Simone ^b   Wolfrum, Katharina ^c   Voigt, Anja ^c   Drewes, Gunnar ^c   Blume, Urte ^a   Bannasch, Peter ^d   Ristow, Michael ^b,e   Steinberg, Pablo ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY OF POTSDAM   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; FRATAXIN; GLUCOSE 6 PHOSPHATE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENOTYPE; GLYCOGEN LIVER LEVEL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER HISTOLOGY; LIVER PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARBOHYDRATE METABOLISM; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLUCOSE-6-PHOSPHATE; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; HEPATOCYTES; IRON-BINDING PROTEINS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL PROTEINS;

ANIMALIA; MUS;

EID: 84856079481     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr499     Document Type: Article

References (49)

1. Bannasch, P. (1968) The cytoplasm of hepatocytes during carcinogenesis. In Rentchnick, P. (eds), Recent Results in Cancer Research, vol. 19. Springer, Berlin/Heidelberg/New York, pp. 1-100.
2. Bannasch, P., Klimek, F. and Mayer, D. (1997) Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J. Bioenerg. Biomembr., 29, 303-313.
3. Moore, M.A., Mayer, D. and Bannasch, P. (1982) The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis, 3, 1429-1436.
4. Hacker, H.J., Moore, M.A., Mayer, D. and Bannasch, P. (1982) Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis, 3, 1265-1272.
5. Enzmann, H. and Bannasch, P. (1987) Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis, 8, 1607-1612.
6. Weber, E. and Bannasch, P. (1994) Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine. Carcinogenesis, 15, 1227-1234.
7. Weber, E. and Bannasch, P. (1994) Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine. Carcinogenesis, 15, 1235-1242.
8. Enzmann, H., Dettler, T., Ohlhauser, D. and Bannasch, P. (1988) Elevation of glucose-6-phosphate in early stages of hepatocarcinogenesis induced in rats by N-nitrosomorpholine. Horm. Metab. Res., 20, 128-129.
9. Bannasch, P., Mayer, D. and Hacker, H.J. (1980) Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim. Biophys. Acta, 605, 217-245.
10. Bannasch, P., Hacker, H.J., Klimek, F. and Mayer, D. (1984) Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv. Enzyme Regul., 22, 97-121.
11. Zerban, H., Radig, S., Kopp-Schneider, A. and Bannasch, P. (1994) Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis, 15, 2467-2473.
12. Grobholz, R., Hacker, H.J., Thorens, B. and Bannasch, P. (1993) Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis. Cancer Res., 53, 4204-4211.
13. Toshkov, I., Chisari, F.V. and Bannasch, P. (1994) Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology, 20, 1162-1172.
14. Radaeva, S., Li, Y., Hacker, H.J., Burger, V., Kopp-Schneider, A. and Bannasch, P. (2000) Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks. J. Hepatol., 33, 580-600.
15. Bannasch, P., Jahn, U.R., Hacker, H.J., Su, Q., Hofmann, W., Pichlmayr, R. and Otto, G. (1997) Focal hepatic glycogenosis: a putative preneoplastic lesion associated with neoplasia and cirrhosis in explanted human livers. Int. J. Oncol., 10, 261-268.
16. Su, Q., Benner, A., Hofmann, W.J., Otto, G., Pichlmayr, R. and Bannasch, P. (1997) Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch., 431, 391-406.
17. Bianchi, L. (1993) Glycogen storage disease I and hepatocellular tumours. Eur. J. Pediatr., 152 (Suppl. 1), S63-S70.
18. OMIM:229300. (2009) Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore, MD. MIM Number: 229300: 6/3/2009. World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/.
19. Campuzano, V., Montermini, L., Lutz, Y., Cova, L., Hindelang, C., Jiralerspong, S., Trottier, Y., Kish, S.J., Faucheux, B., Trouillas, P. et al. (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum. Mol. Genet., 6, 1771-1780.
20. Ristow, M. (2004) Neurodegenerative disorders associated with diabetes mellitus. J. Mol. Med., 82, 510-529.
21. Shoichet, S.A., Baumer, A.T., Stamenkovic, D., Sauer, H., Pfeiffer, A.F., Kahn, C.R., Muller-Wieland, D., Richter, C. and Ristow, M. (2002) Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro. Hum. Mol. Genet., 11, 815-821.
22. Thierbach, R., Schulz, T.J., Isken, F., Voigt, A., Mietzner, B., Drewes, G., von Kleist-Retzow, J.C., Wiesner, R.J., Magnuson, M.A., Puccio, H. et al. (2005) Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span, and tumor growth in mice. Hum. Mol. Genet., 14, 3857-3864.
23. Ciudad, C.J., Carabaza, A. and Guinovart, J.J. (1986) Glucose 6-phosphate plays a central role in the activation of glycogen synthase by glucose in hepatocytes. Biochem. Biophys. Res. Commun., 141, 1195-1200.
24. Carabaza, A., Ciudad, C.J., Baque, S. and Guinovart, J.J. (1992) Glucose has to be phosphorylated to activate glycogen synthase, but not to inactivate glycogen phosphorylase in hepatocytes. FEBS Lett., 296, 211-214.
25. Seoane, J., Gomez-Foix, A.M., O'Doherty, R.M., Gomez-Ara, C., Newgard, C.B. and Guinovart, J.J. (1996) Glucose 6-phosphate produced by glucokinase, but not hexokinase I, promotes the activation of hepatic glycogen synthase. J. Biol. Chem., 271, 23756-23760.
26. Buller, C.L., Loberg, R.D., Fan, M.H., Zhu, Q., Park, J.L., Vesely, E., Inoki, K., Guan, K.L. and Brosius, F.C. 3rd (2008) A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am. J. Physiol. Cell Physiol., 295, C836-C843.
27. Abbud, W., Habinowski, S., Zhang, J.Z., Kendrew, J., Elkairi, F.S., Kemp, B.E., Witters, L.A. and Ismail-Beigi, F. (2000) Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch. Biochem. Biophys., 380, 347-352.
28. Barnes, K., Ingram, J.C., Porras, O.H., Barros, L.F., Hudson, E.R., Fryer, L.G., Foufelle, F., Carling, D., Hardie, D.G. and Baldwin, S.A. (2002) Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell Sci., 115, 2433-2442.
29. Tian, W.N., Braunstein, L.D., Pang, J., Stuhlmeier, K.M., Xi, Q.C., Tian, X. and Stanton, R.C. (1998) Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J. Biol. Chem., 273, 10609-10617.
30. Vizan, P., Alcarraz-Vizan, G., Diaz-Moralli, S., Solovjeva, O.N., Frederiks, W.M. and Cascante, M. (2009) Modulation of pentose phosphate pathway during cell cycle progression in human colon adenocarcinoma cell line HT29. Int. J. Cancer, 124, 2789-2796.
31. Hacker, H.J., Steinberg, P. and Bannasch, P. (1998) Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis, 19, 99-107.
32. Steinberg, P., Klingelhoffer, A., Schafer, A., Wust, G., Weisse, G., Oesch, F. and Eigenbrodt, E. (1999) Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats. Virchows Arch., 434, 213-220.
33. Thierbach, R., Drewes, G., Fusser, M., Voigt, A., Kuhlow, D., Blume, U., Schulz, T.J., Reiche, C., Glatt, H., Epe, B. et al. (2010) The Friedreich's Ataxia protein frataxin modulates DNA base excision repair in prokaryotes and mammals. Biochem. J., 432, 165-172.
34. Seznec, H., Simon, D., Bouton, C., Reutenauer, L., Hertzog, A., Golik, P., Procaccio, V., Patel, M., Drapier, J.C., Koenig, M. et al. (2005) Friedreich ataxia, the oxidative stress paradox. Hum. Mol. Genet., 14, 463-474.
35. Puccio, H., Simon, D., Cossee, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P. and Koenig, M. (2001) Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet., 27, 181-186.
36. Ristow, M., Mulder, H., Pomplun, D., Schulz, T.J., Müller-Schmehl, K., Krause, A., Fex, M., Puccio, H., Müller, J., Isken, F. et al. (2003) Frataxin-deficiency in pancreatic islets causes diabetes due to loss of beta-cell mass. J. Clin. Invest., 112, 527-534.
37. Postic, C., Shiota, M., Niswender, K.D., Jetton, T.L., Chen, Y., Moates, J.M., Shelton, K.D., Lindner, J., Cherrington, A.D. and Magnuson, M.A. (1999) Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem., 274, 305-315.
38. Pearse, A.G.E. (1968) Histochemistry: Theoretical and Applied. Churchill, London.
39. Hellwig, B. and Joost, H.G. (1991) Differentiation of erythrocyte-(GLUT1), liver-(GLUT2), and adipocyte-type (GLUT4) glucose transporters by binding of the inhibitory ligands cytochalasin B, forskolin, dipyridamole, and isobutylmethylxanthine. Mol. Pharmacol., 40, 383-389.
40. Ristow, M., Pfister, M.F., Yee, A.J., Schubert, M., Michael, L., Zhang, C.Y., Ueki, K., Michael, M.D. 2nd, Lowell, B.B. and Kahn, C.R. (2000) Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc. Natl Acad. Sci. USA, 97, 12239-12243.
41. Lang, M. and Michal, G. (1974) In Bergmeyer, H.U. (eds), Methods of Enzymatic Analysis. Verlag Chelie International, Deerfield Beach, pp. 1238-1242.
42. Roe, J.H. and Dailey, R.E. (1966) Determination of glycogen with the anthrone reagent. Anal. Biochem., 15, 245-250.
43. Walker, D.G. and Rao, S. (1964) The role of glucokinase in the phosphorylation of glucose by rat liver. Biochem. J., 90, 360-368.
44. Sutherland, E.W. and Wosilait, W.D. (1956) The relationship of epinephrine and glucagon to liver phosphorylase. I. Liver phosphorylase; preparation and properties. J. Biol. Chem., 218, 459-468.
45. Fiske, C.H. and Subbarow, Y. (1925) The colorimetric determination of phosphorus. J. Biol. Chem., 66, 375-400.
46. Velasco, P., Barcia, R., Ibarguren, I., Sieiro, A.M. and Ramos-Martinez, J.I. (1994) Purification, characterization and kinetic mechanism of glucose-6-phosphate dehydrogenase from mouse liver. Int. J. Biochem., 26, 195-200.
47. van Berkel, T.J., Koster, J.F. and Hulsmann, W.C. (1972) Distribution of L- and M-type pyruvate kinase between parenchymal and Kupffer cells of rat liver. Biochim. Biophys. Acta, 276, 425-429.
48. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
49. Shoichet, S.A., Bäumer, A.T., Stamenkovic, D., Sauer, H., Pfeiffer, A.F., Kahn, C.R., Müller-Wieland, D., Richter, C. and Ristow, M. (2002) Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro. Hum. Mol. Genet., 11, 815-821.